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The programed death-1 (PD-1)–programed death ligand-1 (PD-L1) and PD-L2 co-inhib-
itory pathway has been implicated in the evasion strategies of Mycobacterium tubercu-
losis. Specifically, M. tuberculosis-induced PD-L1 orchestrates expansion of regulatory 
T cells and suppression of Th1 response. However, the role of PD pathway in regulating 
Th17 response to M. tuberculosis has not been investigated. In the present report, we 
demonstrate that M. tuberculosis and M. tuberculosis-derived antigen fractions have 
differential abilities to mediate human monocyte- and dendritic cell (DC)-mediated Th17 
response and were independent of expression of PD-L1 or PD-L2 on aforementioned 
antigen-presenting cells. Importantly, we observed that blockade of PD-L1 or PD-1 did 
not significantly modify either the frequencies of Th17 cells or the production of IL-17 
from CD4+ T cells though IFN-γ response was significantly enhanced. On the contrary, 
IL-1β from monocytes and DCs were critical for the Th17 response to M. tuberculosis. 
Together, our results indicate that IL-1β, but not members of the programed death path-
way, is critical for human Th17 response to M. tuberculosis.
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inTrODUcTiOn
Tuberculosis caused by Mycobacterium tuberculosis still remains a global threat with an estimated 
1.5 million deaths annually. Cellular immunity plays a critical role in mediating the protection 
against tuberculosis. Indeed, IFN-γ-producing CD4+ T helper type 1 cells are critical for the control 
of M. tuberculosis in humans and murine models (1–4). Thus, general paradigm for tuberculosis 
vaccines has largely focused on enhancing the Th1/IFN-γ response (5, 6). However, despite enhanc-
ing IFN-γ response, the recombinant MVA85A vaccine failed to protect infants from tuberculosis 
(7). Therefore, it is pertinent to decipher the role played by other CD4+ T cell subsets and their 
cytokines in mediating immunity against M. tuberculosis.
Th17 cells that express transcription factor RORC and secrete archetype cytokine IL-17A represent 
a distinct subset of CD4+ T cells. Th17 cells also produce IL-17F, IL-21, IL-22, GM-CSF, and IL-26 
and mediate pro-inflammatory responses (8–11). Th17 cells are associated with the pathogenesis of 
several autoimmune and inflammatory diseases (12–14). Evolutionarily, Th17 response is conserved 
to mediate protection at mucosal surfaces and against extracellular pathogens (10, 15). Recent 
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reports have also indicated that Th17 response may play a crucial 
role in mediating protection against intracellular pathogens, such 
as Francisella tularensis and Chlamydia muridarum (16–18). 
These data thus indicate the diverse role of Th17 cells in various 
physiopathologies.
Mycobacterium tuberculosis employs a plethora of mechanisms 
to suppress both innate and adaptive immune responses. The role 
of Th17 response to M. tuberculosis is largely pursued in mice, 
and it remains highly controversial (19–25). Recent reports in 
tuberculosis patients indicate that active disease and its severity 
are associated with low Th17 response (26, 27). Of note, anti-
tuberculosis therapy is associated with enhanced Th17 response, 
suggesting that M. tuberculosis suppresses Th17 response as one 
of the immune evasion mechanisms (28).
Programed death-1 (PD-1)–programed death ligand-1 (PD-
L1)/PD-L2 pathway occupies a unique place in the immune 
evasion strategies employed by M. tuberculosis. Recent data 
highlight the role of PD-1–PD-L1/PD-L2 axis in modulating 
regulatory T  cell (Treg) and Th1 response to M. tuberculosis 
(29–33). Whether this pathway also regulates Th17 response to 
M. tuberculosis is not known. Therefore, in the present study, we 
have evaluated the role of PD pathway members (PD-L1, PD-L2, 
and PD-1) in mediating human monocyte- and dendritic cell 
(DC)-mediated Th17 response to M. tuberculosis.
Several reports have shown that DCs promote Th17 responses 
to either M. tuberculosis or its antigens (34–37). We found that 
monocytes and DCs have differential capacity to promote Th17 
response to M. tuberculosis and M. tuberculosis-derived antigens. 
Notably, a prominent IL-17 response was mediated by DCs in 
comparison to monocytes. Although both monocytes and DCs 
did not express PD-L2, PD-L1 was significantly enhanced upon 
stimulation with M. tuberculosis. Similarly, M. tuberculosis stimu-
lation of monocyte/DC–CD4+ cocultures also lead to significant 
increase in the frequency of PD-1+CD4+ T cells. Importantly, 
blocking PD-L1 or PD-1 neither significantly altered the frequen-
cies of Th17 cells nor augmented IL-17 secretion from CD4+ 
T cells. Analysis of key Th17-polarizing cytokines indicated that 
the production of IL-1β was crucial in the establishment of Th17 
response to M. tuberculosis. These results thus reveal that the out-
come of Th17 response to M. tuberculosis is dictated by the capac-
ity of human innate cells to secrete key Th17-polarizing cytokine 
(IL-1β) and not expression of members of the PD pathway.
MaTerials anD MeThODs
antibodies
FITC-conjugated mAbs to CD86 [clone 2331 (FUN-1)], 
CD274 (clone MIH1), PE-conjugated mAbs to pSTAT3 (clone 
4/P-STAT3), CD80 (clone L307.4), PD-L2 (clone 2D3/B7-H2), 
antigen-presenting cell (APC)-conjugated mAbs to HLA-DR 
(clone G46-6), PD-1 (clone MIH4), Alexa 700-conjugated mAb to 
CD4 (clone RPA-T4), and BV421-conjugated mAb to CD4 were 
from BD Biosciences (Le Pont de Claix, France). PE-conjugated 
mAbs to IL-17A (clone eBio64CAP17), human–mouse RORγt 
(AFKJS-9), APC-conjugated mAb to FoxP3 (clone 236A/E7), and 
Fixable Vibility Dye eFluor® 506 were from eBioscience (Paris, 
France). PE-conjugated mAb to CD40 (clone MAB89) was from 
Beckman Coulter (Villepinte, France). Blocking mAb to human 
PD-L1 (clone MIH1) and isotype control mAb were from eBiosci-
ence. Alexa-488 conjugated mAb to IL-10 (clone JES59D7) and 
blocking mAb to PD-1 (clone EH12.2H7) were from Biolegend 
(London, UK).
M. tuberculosis antigens
γ-irradiated M. tuberculosis (strain H37Rv) and M. tuberculosis 
cell wall, cell membrane cytoplasmic fractions were obtained 
from BEI resources NIAID, NIH.
Purification of immune cells
Peripheral blood mononuclear cells (PBMCs) were obtained 
from buffy bags of healthy donors by Ficoll density gradient 
centrifugation. Buffy bags of the healthy blood donors were pur-
chased from Centre Necker-Cabanel, Etablissement Français du 
Sang, Paris, France. Ethical committee permission was obtained 
for the use of buffy bags of healthy donors (Institut National de la 
Santé et de la Recherche-EFS ethical committee convention 15/
EFS/012). Monocytes and autologous CD4+ T cells were isolated 
from PBMCs by positive selection using the human CD14 and the 
CD4 MicroBeads (Miltenyi Biotec, Paris, France), respectively. 
The cell purity was more than 97%.
generation of Dcs
Monocytes (0.5 × 106 cells/ml) were cultured in the presence of 
granulocyte-macrophage colony-stimulating factor (GM-CSF; 
1,000  IU/106  cells) and IL-4 (500  IU/106  cells) (both cytokines 
from Miltenyi Biotec) for 5 days to obtain immature monocyte-
derived DCs (38). The differentiation of DCs was confirmed by 
flow cytometry.
stimulation of Monocytes and Dcs  
with M. tuberculosis and Their Fractions
Monocytes or DCs (0.5 ×  106/ml) were cultured with (20 μg/
ml) γ-irradiated M. tuberculosis or M. tuberculosis-derived cell 
wall, cell membrane, or cytoplasmic fractions (10  μg/ml) for 
24 h. Activation of DCs and monocytes was assessed based on 
the expression of HLA-DR, CD40, CD80, and CD86 by using 
fluorescence-conjugated mAbs. In addition, induction of PD-L1 
and PD-L2 on these cells was also analyzed.
Monocyte–cD4+ T cell and Dc–cD4+ 
T cell cocultures
Monocytes or DCs (10,000  cells/200  μl/well) were cocultured 
with  autologous CD4+ T cells at a ratio of 1:10 in U-bottom 
96-well  plates and stimulated with (20  μg/ml) γ-irradiated 
M. tuberculosis or M. tuberculosis-derived cell wall, cell membrane, 
or cytoplasmic fractions (10 μg/ml) for 5 days. After 5 days, cell-
free supernatants were collected, and T cells were activated with 
phorbol myristate acetate (50 ng/ml) and ionomycin (500 ng/ml, 
Sigma-Aldrich, France), along with GolgiStop (BD Biosciences), 
for 4 h. For the analysis of IL-17+CD4+ T cells and IL-10+CD4+ 
T cells in the cocultures, surface staining was performed with 
fluorescence-conjugated mAbs to CD4. Then, cells were fixed, 
permeabilized using intracellular staining kit (eBioscience), and 
incubated at 4°C with fluorescence-conjugated mAbs to IL-17A, 
3Stephen-Victor et al. Mycobacterium and Th17 Response
Frontiers in Immunology | www.frontiersin.org November 2016 | Volume 7 | Article 465
IL-10, pSTAT3, and RORC. Samples were acquired by using LSR 
II (BD Biosciences) flow cytometry, and data were analyzed by 
BD FACS DIVA software (BD Biosciences).
For the analysis of FoxP3+CD4+ T in the cocultures, surface 
staining was performed with fluorescence-conjugated mAb to 
CD4. Then, cells were fixed, permeabilized using intracellular 
staining kit (eBioscience), and incubated at 4°C with fluorescence-
conjugated mAb to FoxP3.
For the analysis of PD-1 on CD4+ T cells, surface staining was 
performed with fluorescence-conjugated mAbs to CD4 and PD-1.
PD-l1 and PD-1 Blocking experiment
Autologous monocyte–CD4+ T cell and DC–CD4+ T cell cocul-
tures were stimulated with M. tuberculosis for 18 h. Anti-PD-L1 
(10  μg/ml), anti-PD-1 (10  μg/ml), or isotype control mAbs 
were then added to the coculture. After 5  days, frequency of 
IL-17A+CD4+ T cells and IL-17 secretion were analyzed.
Validation of role for innate cytokines in 
M. tuberculosis-Mediated Th17 responses
Dendritic cells (10,000  cells/200 μl/well) were cocultured with 
autologous CD4+ T cells at a ratio of 1:10 in U-bottom 96-well 
plates and stimulated with (20 μg/ml) γ-irradiated M. tuberculosis 
or M. tuberculosis-derived cytoplasmic fractions (10 μg/ml) either 
alone or in the presence of (10 ng/ml) rhIL-1β (R&D systems, 
Lille, France) or rhIL-23 (PeproTech, Neuilly-Sur-Seine, France) 
for 5 days. After 5 days, cell-free supernatants were collected, and 
T cells were analyzed for Th17 responses by intracellular staining 
as described earlier.
Quantification of cytokines
IL-17A, IFN-γ, IL-6, IL-1β, and IL-23 in the cell-free supernatants 
of monocyte–CD4+ T cell and DC–CD4+ T cell cocultures were 
quantified by ELISA (Ready-SET-Go, eBioscience).
statistical analysis
Statistical analyses were performed by two-way non-parametric 
Mann–Whitney test or one-way ANOVA (Kruskal–Wallis test 
or Holm–Sidak’s multiple comparisons test) as indicated using 
Prism 6 software. P < 0.05 was considered significant.
resUlTs
human Monocytes Promote Th17 
response to M. tuberculosis
Tuberculosis is associated with an expansion of immunomodula-
tory CD16+ monocyte population (39). Monocytes have been 
implicated in the establishment of Th17 response in autoimmune 
diseases (40, 41) and infection (42). We first investigated the 
ability of human monocytes to promote Th17 response to M. 
tuberculosis. We found that M. tuberculosis-stimulated mono-
cytes significantly enhanced both frequency of IL-17A+CD4+ 
T cells (Figures  1A,B) and the amount of secretion of IL-17A 
(Figure  1C). On further examination of downstream Th17 
signaling events in CD4+ T cells, we found that M. tuberculosis-
stimulated monocytes significantly enhanced the frequency of 
pSTAT3 (Figure 1D) and RORC (Figure 1E). These results thus 
suggest that human monocytes have the ability to promote Th17 
response to M. tuberculosis.
Different antigen Fractions of 
M. tuberculosis have similar capacity to 
induce Monocyte-Mediated Th17 response
Mycobacterium tuberculosis possesses a plethora of antigens to 
modulate immune response. Most of these antigens are either 
located in the cell wall, cell membrane, or cytosol. Hence, we 
investigated whether these different antigens of M. tuberculosis 
have similar or distinct ability to mount monocyte-mediated 
Th17 response. All these antigenic fractions induced similar 
level of activation of monocytes as shown by the significantly 
augmented expressions of CD80, CD86, and CD40 (Figure S1 in 
Supplementary Material). Consistent with the activation status of 
monocytes, all the antigen fractions, i.e., cell wall, cell membrane, 
and cytoplasmic fractions significantly enhanced the frequency of 
IL-17A+CD4+ T cells (Figures 2A,B) and the secretion of IL-17A 
(Figure 2C). However, we observed no significant differences in 
the extent of Th17 response mediated by different fractions of M. 
tuberculosis. Our data thus indicate that all the antigen fractions 
of M. tuberculosis have similar ability to promote monocyte-
mediated Th17 responses.
Dendritic cells Differentially Promote 
Th17 response to M. tuberculosis and 
its antigen Fractions
Dendritic cells play a critical role in mediating protection to 
M.  tuberculosis by priming T cell response. Hence, we investi-
gated the capacity of DCs to promote Th17 response to M. tuber-
culosis and its antigen fractions. Our results indicate that DCs 
have the capacity to enhance Th17 response to M. tuberculosis 
(Figures 3A–C). However, in contrast to monocytes, human DCs 
displayed differential ability in stimulating Th17 response to dif-
ferent antigen fractions of M. tuberculosis. Thus, cell wall antigen 
fraction substantially enhanced Th17 response and was compa-
rable to that induced by M. tuberculosis bacteria (Figures 3A–C). 
Although cell membrane fraction also enhanced Th17 response, 
it was lower than that observed with M. tuberculosis bacteria 
and cell wall fraction. Surprisingly, cytoplasmic fraction did not 
significantly enhance either frequencies of IL-17A+CD4+ T cells 
or the production of IL-17A (Figures 3A–C).
We confirm that low-level induction of Th17 response by 
cytoplasmic fraction was not because of lack of induction of 
DC maturation. In fact, DCs stimulated with cytoplasmic frac-
tion significantly enhanced DC maturation markers HLA-DR, 
CD80, CD86, and CD40 and was similar to those observed with 
M. tuberculosis bacteria, cell wall, and cell membrane fractions 
(Figure S2 in Supplementary Material).
Further, the inability of cytoplasmic fraction to promote 
DC-mediated Th17 response was not due to increased frequency 
of suppressor T cells, such as IL-10+CD4+ T cells or FoxP3+CD4+ 
Treg cells. In fact, the frequency of IL-10+CD4+ T cells remain 
unaltered upon stimulation with M. tuberculosis or its antigen 
fractions (Figure  3D). Consistent with the previous findings, 
FigUre 1 | human monocytes stimulated with M. tuberculosis enhance Th17 response. Human peripheral blood monocytes were cocultured with 
autologous CD4+ T cells at a ratio of 1:10 in X-vivo medium for 5 days with or without γ-irradiated M. tuberculosis (Mtb). Th17 cells were analyzed by flow cytometry 
by combination of surface staining for CD4 and intracellular staining for IL-17A, pSTAT3, and ROR-γt. IL-17A in the cell-free supernatants was quantified by ELISA. 
(a,B) Representative dot plots showing the frequencies of CD4+IL-17A+ T cells and (B) median ± SEM data from eight donors. (c) The amount of secretion of 
IL-17A (median ± SEM, n = 8). (D) Percentage of CD4+ T cells positive for pSTAT3 (median ± SEM, n = 4). (e) Percentage of CD4+ T cells positive for ROR-γt 
(median ± SEM, n = 4). *P < 0.05; ***P < 0.001; as determined by Mann–Whitney test.
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M. tuberculosis and its antigen fractions including cytoplasmic 
fraction significantly enhanced the frequency of FoxP3+CD4+ 
Tregs (Figure 3E). However, the extent of stimulation of Treg 
response was similar among all three antigen fractions of M. 
tuberculosis.
Differential expression of PD-l1 on 
Monocytes and Dcs upon stimulation with 
M. tuberculosis and its antigen Fractions
M. tuberculosis employs several strategies to modulate effector 
CD4 T cell response (43). Several recent reports have indicated 
that PD-1–PD-L1/PD-L2 axis has a pivotal role in the regulation 
of T cell response to M. tuberculosis (29, 31, 33). Therefore, to 
decipher the role of PD-L1/PD-L2 in regulating Th17 response 
to M. tuberculosis, we first investigated the ability of M. tubercu-
losis and its different antigen fractions in modulating PD-L1 and 
PD-L2 expression on monocytes and DCs. Our results reveal that 
M. tuberculosis bacteria, cell wall fraction, and cell membrane 
fractions significantly induce PD-L1 expression on both mono-
cytes and DCs (Figures 4A,B). However, significant induction of 
PD-L1 by cytoplasmic fraction was observed only in monocytes 
but not in DCs (Figures  4A,B). Unstimulated monocytes and 
DCs did not express PD-L2 and was not altered upon stimula-
tion with either M. tuberculosis or its different antigen fractions 
(Figures 4C,D).
PD-l1 on human innate cells 
regulates Th1, But not Th17, response 
to M. tuberculosis
PD-1–PD-L1 interaction has been reported to inhibit Th1 
response to M. tuberculosis. To explore if PD-L1 also checks Th17 
response to M. tuberculosis, we employed blocking antibodies to 
PD-L1. We found that blocking PD-L1 either in the monocyte–
CD4+ T cell coculture or in the DC–CD4+ T cell coculture did 
not significantly modify either the frequencies of IL-17A+CD4+ 
T cells or the secretion of IL-17A (Figures 5A–F). These data are 
FigUre 2 | Different antigen fractions of M. tuberculosis have similar capacity to amplify human monocyte-mediated Th17 response. Monocytes were 
cocultured with autologous CD4+ T cells either alone or were stimulated with M. tuberculosis-derived cell wall (CW), cell membrane (CM), or cytoplasmic (Cyt) 
fractions for 5 days. Th17 cells were analyzed by flow cytometry by combination of surface staining for CD4 and intracellular staining for IL-17A. IL-17A in the 
cell-free supernatants was quantified by ELISA. (a,B) Representative dot plots showing the frequencies of CD4+IL-17A+ T cells and (B) mean ± SEM data from six 
independent donors. (c) The amount of secretion of IL-17A (mean ± SEM, n = 6). *P < 0.05; **P < 0.01; as determined by one-way ANOVA.
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in line with the fact that lack of induction of PD-L1 on DCs by 
cytoplasmic fraction of M. tuberculosis was not associated with 
enhanced Th17 responses (Figures  3 and 4B). Whereas, same 
cytoplasmic fraction promoted Th17 response despite it induced 
significant expression of PD-L1 on monocytes (Figures  2 and 
4A). Taken together, these results imply that PD-L1 does not 
function as negative regulator of Th17 response to M. tuberculosis.
It was important to demonstrate that observed phenomenon 
is not due to inefficient PD-L1 blocking. Previous results have 
demonstrated that PD-L1 negatively regulates IFN-γ responses. 
Therefore, to demonstrate the efficiency of PD-L1 blocking, we 
have assessed the secretion of IFN-γ in the monocyte–CD4+ 
T  cell  and DC–CD4+ T cell cocultures. Consistent with the 
previous data, blockade of PD-L1 significantly augmented the 
production of IFN-γ from CD4+ T cells (Figures 6A,B).
PD-1 is Dispensable for the regulation 
of Th17 response to M. tuberculosis
Programed death ligand-1 signals via PD-1 on CD4+ T cells, and 
recently it was reported that Mycobacterium-induced PD-1 coor-
dinates suppression of Th17 response in tuberculosis patients 
(28). We confirm that M. tuberculosis significantly enhances the 
frequency of PD-1+ T cells in the DC/monocyte–CD4+ T cell 
cocultures (Figures  7A,D). However, blockade of PD-1 did 
not significantly alter either the frequencies of IL-17A+CD4+ 
T cells or the secretion of IL-17A (Figures 7B,C,E,F). Similar 
to PD-L1 experiments, blockade of PD-1 also lead to increased 
IFN-γ responses. Together, these data indicate that human 
Th17 response to M. tuberculosis is not under the control of 
PD pathway.
il-1β is critical for Mediating 
Th17 response to M. tuberculosis
Upon encountering with pathogens, APCs secrete various 
cytokines that dictate the outcome of T cell response. Particularly, 
IL-6, IL-1β, and IL-23 derived from innate immune cells play 
a crucial role in establishing and sustaining Th17 response. 
In addition, IL-21 and TGF-β also have important role in Th17 
priming (8, 14). Thus, to decipher the mechanism of differential 
Th17 response to M. tuberculosis and its fractions by monocytes 
and DCs, we analyzed the Th17-polarizing cytokines secreted 
by these innate cells. IL-21 was not produced by monocytes 
and DCs upon stimulation with M. tuberculosis and its antigen 
fractions. Similarly, basal level of TGF-β was not significantly 
altered by M. tuberculosis. However, upon stimulation with M. 
tuberculosis and its antigen fractions, both innate cells secreted 
large quantities of IL-6 (Figures 8A,D) and moderate amounts 
of IL-1β (Figures 8B,E). Of note, monocytes produced signifi-
cantly lower amounts (~10-fold) of IL-23 as compared to DCs 
(Figures 8C,F). Interestingly, consistent with the lack of role in 
the modulation of Th17 response, none of these innate cytokines 
were significantly altered upon blockade of PD-L1 (Figure S3 in 
Supplementary Material).
Despite induction of large quantities of IL-6 in DCs 
similar to those induced by M. tuberculosis or its other anti-
gen fractions, lack of Th17 response by cytoplasmic fraction 
provide a pointer toward dispensability of this cytokine in M. 
tuberculosis-mediated Th17 response. The similar amount of 
IL-1β production by stimulated monocytes explains elicitation 
of Th17 response by all the antigen fractions of M. tuberculosis. 
On the contrary, cytoplasmic fraction was inferior to cell wall 
FigUre 3 | human dendritic cells differentially promote Th17 response to M. tuberculosis and its antigen fractions. Human monocyte-derived DCs were 
cocultured with autologous CD4+ T cells at a ratio of 1:10 in X-vivo medium alone or with γ-irradiated M. tuberculosis (Mtb) or M. tuberculosis-derived cell wall (CW), 
cell membrane (CM), or cytoplasmic (Cyt) fractions for 5 days. Th17 cells were analyzed by flow cytometry by combination of surface staining for CD4 and 
intracellular staining for IL-17A. IL-17A in the cell-free supernatants was quantified by ELISA. (a,B) Representative dot plots showing the frequencies of CD4+IL-
17A+ T cells and (B) mean ± SEM data from seven independent donors. (c) The amount of secretion of IL-17A (mean ± SEM, n = 7). (D,e) Frequencies of 
IL-10+CD4+ T cells or FoxP3+CD4+ Treg cells in DC–T cell cocultures stimulated with various antigens of M. tuberculosis (mean ± SEM, n = 5). *P < 0.05; 
**P < 0.01; ***P < 0.001; ns, not significant; as determined by one-way ANOVA.
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and cell membrane antigen fractions in promoting IL-1β and 
IL-23 by DCs, and this could explain the lack of Th17 responses 
observed in DCs upon stimulation with cytoplasmic frac-
tion. Therefore, to establish a role for IL-1β and IL-23 in M. 
tuberculosis-mediated Th17 responses, we supplemented IL-1β 
or IL-23 to the DC–CD4+ T cell cocultures that are stimulated 
with cytoplasmic fraction of M. tuberculosis. We found that sup-
plementation of IL-1β enabled cytoplasmic fraction-stimulated 
DCs to mount strong Th17 response (Figures 9A,B), while IL-23 
had no effect (Figures 9C,D). Our results thus reveal that innate 
Th17-polarizing cytokine IL-1β but not members of the PD 
pathway. dictates the outcome of human Th17 response to M. 
tuberculosis and its antigen fractions.
DiscUssiOn
M. tuberculosis-loaded aerosols that enter the lungs interact with 
resident phagocytes, which include alveolar macrophages and 
DCs. Different subpopulations of DCs are known to coexist 
in the human lungs (44). Circulating monocytes form a major 
FigUre 4 | Differential expression of PD-l1 and PD-l2 on monocytes 
and dendritic cells upon stimulation with M. tuberculosis and its 
antigen fractions. Monocytes or monocyte-derived DCs were either 
cultured alone or stimulated with γ-irradiated M. tuberculosis or M. 
tuberculosis-derived cell wall (CW), cell membrane (CM), or cytoplasmic (Cyt) 
fractions for 24 h. Surface expressions of PD-L1 (a,B) and PD-L2 (c,D) were 
analyzed by flow cytometry. (a,c) Percentage of monocytes expressing 
PD-L1 and PD-L2 (mean ± SEM, n = 5). (B,D) Percentage of DCs 
expressing PD-L1 and PD-L2 (mean ± SEM, n = 5). **P < 0.01; 
***P < 0.001; ns, not significant; as determined by one-way ANOVA.
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reservoir for tissue macrophages and different subsets of DCs 
(45–47). Moreover, monocytes are known to give rise to DCs 
in vivo at mucosal surfaces, such as skin (48) and lungs (49, 50), 
thus suggesting an in vivo relevance of monocyte-derived DCs in 
mediating immune response to mucosal pathogens, such as M. 
tuberculosis. In comparison to other infections, there is a delay 
in the onset of adaptive immune response upon M. tuberculosis 
infection allowing the bacteria to form a niche in the lungs (51). 
While it is clear that Th1/IFN-γ response is indispensable for 
the protection against tuberculosis, the role of Th17/IL-17 in 
mediating protection is unclear.
Initial studies in mice suggested that the IL-23/Th17 axis is 
dispensable for the overall protection against M. tuberculosis 
challenge but is required for enhancing the formation of granu-
loma in the absence of an active IL-12/Th1 axis (52). Surprisingly, 
Th17 response mediated protection to a highly virulent M. tuber-
culosis strain HN878 by activating macrophages and curtailing 
bacterial burden in the lungs. However, it was dispensable to the 
less virulent strains of M. tuberculosis thus ascribing a protective 
role for Th17 to emerging virulent strains (53). Earlier reports 
in tuberculosis patients indicated that virulent strains, such 
as multi-drug resistant M. tuberculosis, strongly induce Th17 
response. However, enhanced IL-17 was correlated to the sever-
ity of the disease and high bacterial burden in the lungs, suggest-
ing a detrimental role for Th17 response in humans (54). More 
recent reports have demonstrated that tuberculosis patients 
display lower antigen-specific Th17 response. Incidentally, anti-
tuberculosis therapy not only enhanced Th1 response but also 
augmented Th17 response (28). Furthermore, individuals with 
biallelic RORC mutations with a defective Th17 response are 
associated with a compromised Th1 response and are suscepti-
ble to fungal and mycobacterial infections (55). Thus, it appears 
that the protective roles of Th17 response may vary depending 
on the stage of infection. Th17 response contributes to vaccine-
mediated protection and during the earlier stages of infection by 
recruiting lymphocytes and promoting Th1 response. However, 
chronic exposure or during the later stages of infection it may 
be detrimental due to neutrophil recruitment that can mediate 
tissue damage leading to immunopathology.
Previous studies have shown that DCs can mediate Th17 
response to M. tuberculosis by signaling through TLR-2, dectin-1, 
DC-SIGN, and mannose receptors (36, 53, 56). In the present 
study, we show that monocytes and DCs have differential capacity 
to modulate Th17 responses to M. tuberculosis and M. tuberculosis-
derived antigen fractions. Notably, DCs evoked a much stronger 
IL-17A production from CD4+ T cells than monocytes. This 
might be due to the capacity of DCs to secrete large quantities 
of IL-23 than monocytes. IL-23 plays an important role in sta-
bilizing and sustaining the ensuing Th17 response. Interestingly, 
unlike monocytes that promoted Th17 response to cell wall, 
cell membrane, and cytoplasmic fractions of M. tuberculosis, 
DCs displayed differential response to these antigen fractions. 
Thus, cell wall fraction triggered strong DC-mediated IL-17A 
production from CD4+ T cells; cell membrane fraction promoted 
intermediate IL-17A response, and the cytoplasmic fraction did 
not significantly modulate Th17 response. As immuno suppres-
sor T cells have the ability to inhibit effector T cell responses, we 
surmised whether increased frequency of IL-10+CD4+ T cells or 
FoxP3+CD4+ Treg cells was responsible for low-level induction of 
DC-mediated Th17 responses by cytoplasmic fraction of M. tuber-
culosis (57–60). However, IL-10+CD4+ T cells were not induced 
under any stimulatory conditions. Although cytoplasmic fraction 
significantly enhanced the frequency of FoxP3+CD4+ Treg cells, 
this increase was similar to that observed with M. tuberculosis and 
other antigen fractions.
Suppression of cellular immunity reckons a major evasion 
strategy employed by M. tuberculosis. Of the numerous eva-
sion strategies employed by M. tuberculosis, the exploitation 
of PD-L1/PD-L2–PD-1 axis occupies a central role due to its 
implication in the expansion of Treg response and suppression 
of effector Th1 response (61, 62). Considering that induced 
Tregs and Th17 responses are reciprocally regulated, the possible 
role of PD-L1/PD-L2 in regulating Th17 response has not been 
questioned. It is well established that M. tuberculosis infection 
induces PD-L1 on APCs and PD-1 on T cells. Interaction of 
PD-L1 with PD-1 promotes Treg differentiation and expansion 
by activating SHP1/2. Induced SHP1/2 suppresses STAT1 func-
tions, abrogates IFN-γ production, and abolishes its inhibitory 
effect on FOXP3 leading to Treg expansion (63). Since PD-1 axis 
plays a critical role in mediating immune tolerance and loss of 
which can predispose to inflammatory conditions and autoim-
mune diseases (64, 65), it is deleterious to completely abrogate 
PD-L1–PD-1 signaling during M. tuberculosis infection. This is 
FigUre 5 | PD-l1 on human innate cells is dispensable for regulating Th17 response to M. tuberculosis. Monocytes or DCs were cocultured with 
autologous CD4+ T cells either alone or with γ-irradiated M. tuberculosis. After 18 h, PD-L1 blocking mAb or isotype control mAb were added, and cultures were 
maintained for 5 days. Th17 cells were analyzed by flow cytometry by combination of surface staining for CD4 and intracellular staining for IL-17A. IL-17A in the 
cell-free supernatants was quantified by ELISA. (a–c) Representative dot plots showing the frequencies of CD4+IL-17A+ T cells (a), frequencies of CD4+IL-17A+ T 
cells (mean ± SEM, n = 5) (B), and amounts of IL-17A production (mean ± SEM, n = 6) (c) in monocyte–CD4+ T cell cocultures. (D–F) Representative dot plots 
showing the frequencies of CD4+IL-17A+ T cells (D), frequencies of CD4+IL-17A+ T cells (mean ± SEM, n = 6) (e), and amounts of IL-17A production (mean ± SEM, 
n = 6) (F) in DC–CD4+ T cell cocultures. *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant; as determined by one-way ANOVA.
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evidenced by the fact that PD-L1-deficient and PD-1-deficient 
mice are susceptible to M. tuberculosis infection and display 
exacerbated inflammation (66, 67).
In the present study, we found that monocytes stimulated 
with M. tuberculosis and its antigen fractions significantly induce 
PD-L1 expression on human monocytes. On the contrary, only 
FigUre 6 | PD-l1 on human innate cells regulates Th1 response to 
M. tuberculosis. Monocytes or DCs were cocultured with autologous CD4+ 
T cells either alone or with γ-irradiated M. tuberculosis. After 18 h, PD-L1 
blocking mAb or isotype control mAb were added, and cultures were 
maintained for 5 days. Amounts of secretion of IFN-γ in monocyte–CD4+ T 
cell cocultures (a) and in DC–CD4+ T cell cocultures (mean ± SEM, n = 6) 
(B). *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant; as determined by 
one-way ANOVA.
FigUre 7 | PD-1 is dispensable for the regulation of Th17 response to M. tuberculosis. Monocytes or DCs were cocultured with autologous CD4+ T cells 
either alone or with γ-irradiated M. tuberculosis. After 18 h, PD-1 blocking mAb or isotype control mAb were added, and cultures were maintained for 5 days. (a–c) 
Frequency of PD-1+CD4+ T cells (mean ± SEM, n = 4) (a), frequency of CD4+IL-17A+ T cells (mean ± SEM, n = 6) (B), and amounts of IL-17A production 
(mean ± SEM, n = 6) (c) in the monocyte–CD4+ T cell cocultures. (D–F) Frequency of PD-1+CD4+ T cells (mean ± SEM, n = 4) (D), frequency of CD4+IL-17A+ 
T cells (mean ± SEM, n = 6) (e), and amounts of IL-17A production (mean ± SEM, n = 6) (F) in the DC–CD4+ T cell cocultures. *P < 0.05; **P < 0.01; ns, not 
significant; as determined by one-way ANOVA.
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and DCs under any stimulatory conditions. The inability of 
cytoplasmic fraction to induce PD-L1 on DCs was not due to 
its lack of stimulatory capacity as cytoplasmic fraction inducted 
DC maturation similar to that of cell wall and cell membrane 
fractions.
To decipher the role PD-L1 in regulating Th17 response to 
M. tuberculosis, we employed blocking antibodies to PD-L1. Our 
results demonstrate that PD-L1 blockade did not significantly 
alter the frequencies of Th17 cells. On the other hand, IFN-γ 
production was significantly enhanced when PD-L1 was blocked, 
thus confirming the previous data on role of PD axis in regulat-
ing Th1 responses (31, 32). However, we did observe a marginal 
(~50 pg/ml) but insignificant increase in IL-17 production upon 
PD-L1 blockade. As Th17 cells and Tregs are reciprocally regu-
lated and moreover Tregs are known to suppress Th17 response 
(66, 68, 69), it is likely that blockade of PD-L1 can indirectly favor 
Th17 response to a certain extent. This could explain minimal 
augmentation of IL-17A production that we observed upon 
PD-L1 blockade.
In addition to PD-L1, M. tuberculosis significantly enhanced 
PD-1 on CD4+ T cells. However, PD-1 blockade had no 
repercussion on either monocyte- or DC-mediated Th17 
response. Our data contradict a recent report that indicated that 
cell wall and cell membrane fractions induced PD-L1 expression 
on DCs, whereas the cytoplasmic fraction failed to enhance 
PD-L1 on DCs. PD-L2 was not expressed on both monocytes 
FigUre 8 | Production of Th17 priming cytokines by human innate cells upon stimulation with M. tuberculosis or its antigen fractions. Monocytes or 
DCs were cocultured with autologous CD4+ T cells either alone or stimulated with γ-irradiated M. tuberculosis or M. tuberculosis-derived cell wall (CW), cell 
membrane (CM), or cytoplasmic (Cyt) fractions for 5 days. Cell-free supernatants were analyzed for the secretion of innate cytokines by ELISA. (a–c) IL-6, IL-1β, 
and IL-23 production by monocytes (mean ± SEM, n = 5) and (D–F) IL-6, IL-1β, and IL-23 production by DCs (mean ± SEM, n = 6). *P < 0.05; **P < 0.01; 
***P < 0.001; ns, not significant; as determined by one-way ANOVA.
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Mycobacterium-induced PD-1 orchestrates suppression of Th17 
response in tuberculosis patients (28). This discrepancy might 
be due to the fact that previous report focused on active disease 
where prolonged infection can enhance additional co-stimulatory 
molecules that might not be present during the earlier phases of 
stimulation. For example, APCs from active disease express both 
the co-stimulatory molecules PD-L1 and PD-L2 (31), whereas 
our current data and previous reports show that DCs from 
healthy individuals stimulated with M. tuberculosis both at the 
transcript level as well as the protein level induce only PD-L1 
and not PD-L2 (30, 33). It is essential to note that we have used 
γ-irradiated M. tuberculosis or M. tuberculosis-derived cell wall, 
cell membrane, or cytoplasmic fractions in our experiments, and 
these conditions may not completely mimic in vivo situation of 
infection with live bacteria. Therefore, further work is necessary 
to decipher the role of PD-1–PD-L1/PD-L2 pathway in tubercu-
losis. Nevertheless, our report indicates that PD pathway does not 
contribute to negative regulation of human Th17 response to M. 
tuberculosis. Also, cytoplasmic fraction of M. tuberculosis failed to 
induce Th17 response despite lack of induction of PD-L1 on DCs.
To decipher the possible mechanism that explains inabil-
ity of cytoplasmic fraction to promote DC-mediated Th17 
response, we analyzed key Th17-polarizing cytokines secreted 
by monocytes and DCs. Our results indicate that cytoplasmic 
fraction failed to induce IL-1β, the key cytokine that promotes 
Th17 response. The amounts of secretion of IL-1β and Th17 
responses were significantly correlated. Importantly, exogenous 
supplementation of IL-1β was sufficient to significantly augment 
Th17 response by the cytoplasmic fraction. These results indicate 
that inability of cytoplasmic fraction to induce the production 
of IL-1β from DCs resulted in its failure to prime a robust 
Th17 response. Further work on mechanisms underlying the 
differential production of IL-1β from monocytes and DCs 
upon stimulation with cytoplasmic fraction is warranted (70). 
Distinct expression of pattern-recognition receptors that sense 
cytoplasmic fraction on monocytes and DCs might have resulted 
in the differential IL-1β secretion upon stimulation with the 
cytoplasmic fraction. Therefore, antigens that come in direct 
contact with innate immune cells, such as the cell wall antigens, 
are attractive candidates for future tuberculosis vaccines. It is 
important to note that IL-1β is a critical mediator of immunity 
to M. tuberculosis (71, 72). Our results suggest that this function 
of IL-1β is in part via enhancement of Th17 responses. As tuber-
culosis patients were reported to exhibit lower antigen-specific 
Th17 response (28), supplementing IL-1β might enhance Th17 
response.
Taken together, our report demonstrates that DCs have dif-
ferential capacity to mediate Th17 response to various antigen 
fractions of M. tuberculosis. Therefore, cell wall antigens of 
M. tuberculosis constitute potential subunit vaccine candidates. 
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Importantly, we demonstrate that PD pathway is critical for 
regulating Th1, but not Th17, response to M. tuberculosis. IL-1β 
however is necessary for promoting a prominent Th17 response 
to M. tuberculosis.
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FigUre s1 | M. tuberculosis and its antigen fractions enhance 
costimulatory molecules on monocytes. Monocytes (0.5 × 106/ml) were 
either cultured alone or stimulated with γ-irradiated M. tuberculosis (Mtb) or M. 
tuberculosis-derived cell wall (CW), cell membrane (CM), or cytoplasmic (Cyt) 
fractions for 24 h. (a–D) Surface expression of CD80 [mean fluorescence 
intensity (MFI), CD86 (% positive cells), CD40 (MFI), and HLA-DR (MFI)] 
(mean ± SEM, n = 5) was analyzed by flow cytometry. **P < 0.01; ns, not 
significant; as determined by one-way ANOVA.
FigUre s2 | M. tuberculosis-derived cytoplasmic fraction induce 
maturation of Dcs. DCs (0.5 × 106/ml) were either cultured alone or stimulated 
with γ-irradiated M. tuberculosis (Mtb) or M. tuberculosis-derived cell wall (CW), 
cell membrane (CM), or cytoplasmic (Cyt) fractions for 24 h. (a–D) Surface 
expression of CD80 [mean fluorescence intensity (MFI), CD86 (% positive cells), 
CD40 (MFI), and HLA-DR (MFI)] (mean ± SEM, n = 4) was analyzed by flow 
cytometry. *P < 0.05; **P < 0.01; ***P < 0.001; as determined by one-way 
ANOVA.
FigUre s3 | Production of Th17-polarizing cytokines by human innate 
cells upon PD-l1 blockade. Monocytes or DCs were cocultured with 
autologous CD4+ T cells either alone or stimulated with γ-irradiated M. 
tuberculosis (Mtb). After 18 h, PD-L1 blocking mAb or isotype control mAb were 
added, and cultures were maintained for 5 days. Cell-free supernatants were 
analyzed for the secretion of innate cytokines by ELISA. (a–c) IL-6, IL-1β, and 
IL-23 production by monocytes and (D–F) IL-6, IL-1β, and IL-23 production by 
DCs (mean ± SEM, n = 7). *P < 0.05; **P < 0.01; ***P < 0.001; ns, not 
significant; as determined by one-way ANOVA.
FigUre 9 | il-1β is critical for mediating Th17 response to M. 
tuberculosis. DCs were cocultured with autologous CD4+ T cells either 
alone or stimulated with γ-irradiated M. tuberculosis, M. tuberculosis-derived 
cytoplasmic (Cyt) fraction, or Cyt fraction in combination with exogenous 
IL-1β (a,B) or IL-23 (c,D) for 5 days. Frequencies of CD4+IL-17A+ T cells 
(mean ± SEM, n = 4–6) (a,c) and amounts of IL-17A production 
(mean ± SEM, n = 4–6) (B,D) in DC–CD4+ T cell cocultures. *P < 0.05; 
**P < 0.01; ns, not significant; as determined by one-way ANOVA.
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